WallStreetZenWallStreetZen

NASDAQ: GLUE
Monte Rosa Therapeutics Inc Stock Ownership - Who owns Monte Rosa Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Monte Rosa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Markus WarmuthCEO;Pres2026-07-169,500$23.18
$220.22kSell
Jennifer ChampouxCOO2026-07-154,351$3.98
$17.32kBuy
Jennifer ChampouxCOO2026-07-154,351$23.38
$101.73kSell
Sharon TownsonChief Scientific Officer2026-07-066,000$6.14
$36.84kBuy
Sharon TownsonChief Scientific Officer2026-07-065,600$23.25
$130.20kSell
Sharon TownsonChief Scientific Officer2026-07-06400$24.13
$9.65kSell
Filip JankuChief Medical Officer2026-06-305,407$24.50
$132.47kSell
Filip JankuChief Medical Officer2026-06-305,407$13.41
$72.51kBuy
Filip JankuChief Medical Officer2026-06-296,000$22.95
$137.70kSell
Anthony M. ManningDirector2026-06-2910,000$23.11
$231.10kSell

1 of 6

GLUE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GLUE insiders and whales buy or sell their stock.

GLUE Shareholders

What type of owners hold Monte Rosa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bradley J. Phd Bolzon10.43%8,897,053$133.72MInsider
Versant Venture Capital VI LP9.09%7,750,860$116.50MInsider
Forest Baskett9.02%7,692,298$115.62MInsider
Carmen Chang9.02%7,692,298$115.62MInsider
Anthony A. Florence Jr.9.02%7,692,298$115.62MInsider
Liza Landsman9.02%7,692,298$115.62MInsider
Mohamad Makhzoumi9.02%7,692,298$115.62MInsider
Joshua Makower9.02%7,692,298$115.62MInsider
Edward T. Mathers9.02%7,692,298$115.62MInsider
New Enterprise Associates 17 LP9.02%7,692,298$115.62MInsider

1 of 3

GLUE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLUE0.08%99.92%Net SellingNet Selling
SPTX0.07%74.84%Net BuyingNet Buying
NVAX0.07%17.14%Net Selling
MNKD0.06%97.25%Net SellingNet Selling
DRTS0.01%0.58%Net SellingNet Selling
View Top Biotech Stocks

Monte Rosa Therapeutics Stock Ownership FAQ

Who owns Monte Rosa Therapeutics?

Monte Rosa Therapeutics (NASDAQ: GLUE) is owned by 0.11% institutional shareholders, 140.37% Monte Rosa Therapeutics insiders, and 0.00% retail investors. Bradley J. Phd Bolzon is the largest individual Monte Rosa Therapeutics shareholder, owning 8.90M shares representing 10.43% of the company. Bradley J. Phd Bolzon's Monte Rosa Therapeutics shares are currently valued at $133.72M.

If you're new to stock investing, here's how to buy Monte Rosa Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.